UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057994
Receipt number R000066283
Scientific Title A study to evaluate the effects of food ingredients on taste sensitivity
Date of disclosure of the study information 2025/05/29
Last modified on 2025/12/09 16:56:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study to evaluate the effects of food ingredients on taste sensitivity

Acronym

A study to evaluate the effects of food ingredients on taste sensitivity

Scientific Title

A study to evaluate the effects of food ingredients on taste sensitivity

Scientific Title:Acronym

A study to evaluate the effects of food ingredients on taste sensitivity

Region

Japan


Condition

Condition

None

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm the effects of food ingredients on taste sensitivity

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Taste evaluation after 4 weeks of intervention

Key secondary outcomes

Taste evaluation using VAS (Visual Analog Scale)
Amount of tongue coating
Salivary secretion volume during masticatory stimulation
Blood pressure
Questionnaire on taste and oral condition


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Hold a solution containing food ingredients in the mouth twice a day, for 3 minutes each time, every day for 4 weeks.

Interventions/Control_2

Hold a placebo solution in the mouth twice a day, for 3 minutes each time, every day for 4 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

25 years-old <=

Age-upper limit

64 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Males and females aged 25 to 64 years old
2.People who cannot recognize any of the second lowest concentrations in the taste test
3.People who have given informed consent to participate in the study of their own free will

Key exclusion criteria

1.People diagnosed with or having a history of taste disorders
2.People who regularly use medications that can cause taste disorders or have taken them from two weeks before the test until the start of the test
3.People who regularly take medicines, supplements, or foods containing zinc that may improve taste, or have taken them from two weeks before the test until the start of the test
4.People who are currently smoking
5.People diagnosed with Sjogren's syndrome or dry mouth
6.People diagnosed with or having a history of Sjogren's syndrome or dry mouth
7.People with cerebral infarction, chronic ear infections, chronic runny nose, sinusitis, history of stomach surgery, chronic kidney disease, diabetes, or cancer
8.People receiving radiation therapy
9.People who are pregnant or might be pregnant
10.People with tongue problems or chronic tongue pain
11.People who cannot consume sucrose (sweet), sodium chloride (salty), citric acid (sour), or quinine (bitter) at all
12.People allergic to the test food ingredients or who get itchy or rashes from products with these ingredients
13.People allergic to quinine or who get itchy or rashes from foods with quinine
14.People who have had allergic reactions (including skin itchiness or rashes) or other issues from using dental products like toothpaste or mouthwash, or cosmetics
15.People who are sensitive or allergic to alcohol (like getting itchy or rashes)
16.People with tooth loss other than wisdom teeth, except when due to past orthodontic treatment or accidental injury
17.People wearing braces or other orthodontic devices
18.People with tongue piercings or tattoos
19.People with strict diets that favor or avoid certain foods (like Halal, vegan)
20.People taking part or planning to take part in other oral health or function studies
21.People considered unsuitable by the main researcher

Target sample size

24


Research contact person

Name of lead principal investigator

1st name Kei
Middle name
Last name Kurita

Organization

Lion corporation

Division name

Advanced oral health science research laboratories

Zip code

132-0035

Address

7-2-1 Hirai, Edogawa-ku, Tokyo, Japan

TEL

03-3616-3796

Email

kei-k@lion.co.jp


Public contact

Name of contact person

1st name Kei
Middle name
Last name Kurita

Organization

Lion corporation

Division name

Advanced oral health science research laboratories

Zip code

132-0035

Address

7-2-1 Hirai, Edogawa-ku, Tokyo, Japan

TEL

03-3616-3796

Homepage URL


Email

kei-k@lion.co.jp


Sponsor or person

Institute

LION corporation

Institute

Department

Personal name



Funding Source

Organization

LION corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Lion corporation

Address

1-3-28, Kuramae, Taito-ku, Tokyo, Japan

Tel

03-6739-3711

Email

tohki@lion.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 05 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

31

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2025 Year 03 Month 28 Day

Date of IRB

2025 Year 04 Month 04 Day

Anticipated trial start date

2025 Year 05 Month 30 Day

Last follow-up date

2026 Year 05 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 05 Month 28 Day

Last modified on

2025 Year 12 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066283